News
-
-
-
-
-
-
-
PRESS RELEASE
Biotests’ positive fibrinogen phase III trial results published in The Lancet’s eClinicalMedicine
Biotest AG announces positive phase III trial results for fibrinogen concentrate BT524 in reducing bleeding, with potential regulatory approval in Europe and U.S. pending. Study data to be presented at ISTH 2025 Congress -
-
-